Tuesday, March 15, 2016 11:41:11 AM
The Threshold Pharmaceuticals chart doesn't look all that different, in that THLD shares have been just drifting sideways for months following a nasty December plunge. Were it just today that we saw a big gain (of 78%), it might be dismissible. A closer look at this chart, however, reveals that this rally has actually been underway for almost two weeks now. Something's up, and though yesterday afternoon's release of the company's Q4 results will get the credit for Friday's advance, it at least has to be acknowledged the party started well in advance of the news.
In any case, Threshold Pharmaceuticals was profitable last quarter, earning income of $69.7 million, or 62 cents per share. Both the top line and the bottom line trounced analyst estimates. More than that though, the numbers may be forcing the whole market to rethink its view of the opportunity THLD brings to the table.
> link http://www.smallcapnetwork.com/Fridays-Hottest-Penny-Stocks-Threshold-Pharmaceuticals-THLD-Ascent-Solar-Technologies-ASTI-GlobeImmune-GBIM/s/via/1789/article/view/p/mid/2/id/227/
link http://microcapspot.com/threshold-pharmaceuticals-inc-nasdaqthld-stages-impressive-rally/635/
Recent MTEM News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:13:13 PM
- Molecular Templates, Inc. Provides Interim Update • GlobeNewswire Inc. • 06/03/2024 12:11:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:21:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 09:18:03 PM
- Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update • GlobeNewswire Inc. • 05/15/2024 09:11:54 PM
- Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patien • GlobeNewswire Inc. • 04/09/2024 12:11:00 PM
- Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update • GlobeNewswire Inc. • 03/29/2024 12:21:08 PM
- Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement • GlobeNewswire Inc. • 03/28/2024 12:11:00 PM
- Molecular Templates, Inc. Provides Interim Update • GlobeNewswire Inc. • 03/04/2024 01:11:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 01:39:50 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:45:31 PM
- Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/08/2024 10:55:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 10:49:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 10:34:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 10:32:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:04:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:13:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:12:59 PM
- Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update • GlobeNewswire Inc. • 11/13/2023 09:11:00 PM
- Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors • GlobeNewswire Inc. • 11/02/2023 08:11:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 08:14:59 PM
- Molecular Templates to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/01/2023 08:12:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:46:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:46:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:46:09 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM